Diabetes Australia supporting research into the causes of type 1 diabetes 23 January 2019 With the support of a grant from the Diabetes Australia Research Trust, Dr Andrew Sutherland from St Vincent’s Institute Medical Research is studying a new way of potentially preventing and treating type 1 diabetes. “There are a class of immune cells, Th17, that can play a role in the development of type 1 diabetes so we want to identify the molecules these cells produce. This could pave the way for the development of new therapies,” Dr Sutherland said. “My research will be looking specifically at IL-17F, a protein produced by Th17 that is responsible for cell signaling, that hasn’t previously been studied in type 1 diabetes. “We have shown that IL-17F causes the dysfunction and death of pancreatic beta cells which may be an important pathway that leads to type 1 diabetes. “Hopefully, if we can inhibit the function of IL-17F then we can prevent or treat type 1 diabetes in mice. “If it works in the mouse model, then IL-17F inhibitors could be good candidates for a clinical trial of a drug to prevent type 1 diabetes.”
Blog 21 May 2024 Pasifika diabetes research focuses on women In world-first research, Maori and Pasifika women share their journeys on film during their 24-week interventions to study self-management of type 2 diabetes. This study was made possible by Diabetes Australia Research Program funding. Continue Reading
Media releases 15 May 2024 Diabetes Australia welcomes cost relief in 2024-25 Federal Budget Diabetes Australia welcomes health measures providing cost of living relief in this year's Federal Budget. DA eagerly awaits the outcomes of the current Senate Inquiry into Diabetes. Continue Reading
News 14 May 2024 New PBS listing for treatment of itch associated with chronic kidney disease A new medication has been added to the PBS for people undergoing dialysis and experiencing chronic kidney disease itch. Continue Reading